started · updated
Alzchem Group expands capacity amid creatine and nitroguanidine demand
Alzchem Group is experiencing growth driven by high demand for high-purity creatine and nitroguanidine. After nine months, the company reported a 4 percent increase in revenue and an 8 percent rise in EBITDA.
In Trostberg, Germany, the company is investing approximately 120 million euros to expand production capacities, with operations expected to begin in the second half of 2027. Additionally, Alzchem is planning a new factory in the United States to produce nitroguanidine, a raw material considered strategically important to Washington. The U.S. government has reportedly funded all project costs to date.
Analysts expect Alzchem to report quarterly earnings on October 29, 2026, with an estimated earnings per share of 1.43 EUR and revenue of approximately 143.4 million EUR.
Entities
Alzchem Group · Andreas Lößler · China · Trostberg · United States